Literature DB >> 3789133

Changes in plasma albumin concentration, synthesis rate, and mRNA level during acute inflammation.

W S Liao, L S Jefferson, J M Taylor.   

Abstract

Induction of acute inflammation in rats by the subcutaneous injection of turpentine resulted in a marked fall in the concentration of albumin in plasma. This fall, which reached a minimum of 45% of the control level at 36 h after injection of the inflammatory agent, occurred in the presence of no significant change in the concentration of total protein in plasma. It was accompanied by a corresponding decline in the relative abundance of albumin mRNA in liver, which reached a minimum of 25% of the control level at 36 h after initiation of the inflammatory response. Perfused livers from 36-h postinjection rats exhibited albumin secretion rates that were reduced to 38% of control values. In contrast, release of total secretory proteins, secretion of nonalbumin plasma proteins, and synthesis of nonexported proteins by perfused livers were elevated to 166, 266, and 117% of the control values, respectively, as a result of the inflammatory response. These results demonstrate that acute inflammation causes a relative reduction in hepatic albumin mRNA, which leads to a corresponding decrease in albumin synthesis and secretion by liver and a fall in the concentration of albumin in plasma. The concentration of total protein in plasma is maintained during acute inflammation in part by increased synthesis and secretion by liver of nonalbumin plasma proteins, e.g. the acute-phase reactants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789133     DOI: 10.1152/ajpcell.1986.251.6.C928

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.

Authors:  Kevin A Strauss; Charles E Ahlfors; Kyle Soltys; George V Mazareigos; Millie Young; Lauren E Bowser; Michael D Fox; James E Squires; Patrick McKiernan; Karlla W Brigatti; Erik G Puffenberger; Vincent J Carson; Hendrik J Vreman
Journal:  Hepatology       Date:  2020-02-05       Impact factor: 17.425

Review 2.  The clinical use of albumin: the point of view of a specialist in intensive care.

Authors:  Pietro Caironi; Luciano Gattinoni
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

3.  Acute phase reactants in Sudanese children with severe protein-energy malnutrition.

Authors:  Omer S M Suliman; Mustafa A M Salih; Zein A Karrar; Abdelrahim O Mohammed; Chrestover Helsing
Journal:  Sudan J Paediatr       Date:  2011

4.  Stimulation of the acute-phase response in simian virus 40-hepatocyte cell lines.

Authors:  W S Liao; K T Ma; C D Woodworth; L Mengel; H C Isom
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

5.  Association Between Serum Albumin and Hospital-Acquired Infections After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Peng Wang; Yu Zhang; Xing Wang; Liyuan Peng; Lu Jia; Tiangui Li; Weelic Chong; Yang Hai; Chao You; Fang Fang
Journal:  Neurocrit Care       Date:  2021-12-30       Impact factor: 3.532

6.  The transport of DDT from chylomicrons to adipocytes does not mimic triacylglycerol transport.

Authors:  Alison B Kohan; Abbey E Vandersall; Qing Yang; Min Xu; Ronald J Jandacek; Patrick Tso
Journal:  Biochim Biophys Acta       Date:  2012-08-03

7.  Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis.

Authors:  Chi Chen; Yatrik M Shah; Keiichirou Morimura; Kristopher W Krausz; Makoto Miyazaki; Terrilyn A Richardson; Edward T Morgan; James M Ntambi; Jeffrey R Idle; Frank J Gonzalez
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

Review 8.  Debate: Albumin administration should be avoided in the critically ill.

Authors:  T B Pulimood; G R Park
Journal:  Crit Care       Date:  2000       Impact factor: 9.097

9.  C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy.

Authors:  Alina Frey; Daniel Martin; Louisa D'Cruz; Emmanouil Fokas; Claus Rödel; Maximilian Fleischmann
Journal:  Biomedicines       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.